Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors
A series of 3,4,6-substituted 2-quinolones has been synthesized and evaluated as FMS inhibitors. A series of 3,4,6-substituted 2-quinolones has been synthesized and evaluated as inhibitors of the kinase domain of macrophage colony-stimulating factor-1 receptor (FMS). The fully optimized compound, 4-...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2008-03, Vol.18 (6), p.2097-2102 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A series of 3,4,6-substituted 2-quinolones has been synthesized and evaluated as FMS inhibitors.
A series of 3,4,6-substituted 2-quinolones has been synthesized and evaluated as inhibitors of the kinase domain of macrophage colony-stimulating factor-1 receptor (FMS). The fully optimized compound, 4-(4-ethyl-phenyl)-3-(2-methyl-3
H-imidazol-4-yl)-2-quinolone-6-carbonitrile
21b, has an IC
50 of 2.5
nM in an in vitro assay and 5.0
nM in a bone marrow-derived macrophage cellular assay. Inhibition of FMS signaling in vivo was also demonstrated in a mouse pharmacodynamic model. |
---|---|
ISSN: | 0960-894X 0968-0896 1464-3405 1464-3391 |
DOI: | 10.1016/j.bmcl.2008.01.088 |